Q2 2025 Management View Kevin Sayer, CEO, announced "second quarter organic revenue growth of 15% compared to the second quarter of 2024," attributing strong performance to "focused execution by our ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 1, 2025. Management will ...

Welcome to the DexCom First Quarter 2025 Earnings Release Conference Call. My name is Louella, and I will be your operator for today's call. [Operator Instructions] As a reminder, the conference is ...

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman ...

Feb 13 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab beat fourth-quarter sales estimates helped by resilient demand for its continuous glucose monitors (CGMs) used by patients with ...

DexCom, Inc. DXCM reported third-quarter 2025 adjusted earnings per share (EPS) of 61 cents, which beat the Zacks Consensus Estimate of 57 cents by 7%. The company reported earnings of 45 cents per ...

Jan 13 (Reuters) - Dexcom (DXCM.O), opens new tab forecast total annual revenue largely in line with Wall Street expectations on Monday, on bets there will be strong demand for its continuous glucose ...

Ladies and gentlemen, welcome to the DexCom Second Quarter 2025 Earnings Release Conference Call. My name is Abby, and I'll be your conference operator today. [Operator Instructions] As a reminder, ...

Dexcom forecast total annual revenue largely in line with Wall Street expectations on Monday, on bets there will be strong demand for its continuous glucose monitors for diabetes patients, sending the ...